Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

OCT4 Antibody (OTI9B7), Janelia Fluor™ 549, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP271225JF549

Catalog No. N271225J549


Only null left
Add to Cart

Description

Description

44473 Monoclonal specifically detects 44473 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
Specifications

Specifications

OCT4
Monoclonal
Janelia Fluor 549
50mM Sodium Borate with 0.05% Sodium Azide
POU5F1
Full length recombinant protein of human OCT4 (NP_002692) produced in E.coli.
0.1 mL
Primary
Human
IgG1
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI9B7
Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
class 5, transcription factor 1, MGC22487, Oct-3, OCT3Oct4, Oct-4, Octamer-binding protein 3, otc-4, OTF3POU domain class 5, transcription factor 1, OTF4, POU class 5 homeobox 1, POU-type homeodomain-containing DNA-binding protein
Mouse
Affinity Purified
Cellular Markers, Chromatin Research, Embryonic Stem Cell Markers, Glia Markers, Neuroscience, Oligodendrocyte Cell Markers, Pancreatic Stem Cell Markers, Stem Cell Markers, Stem Cells, Transcription Factors and Regulators
5460.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.